Clinical Trial Update: The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the impact of choline acetyltransferase and apolipoprotein Epsilon gene polymorphisms on response to donepezil in Alzheimer's d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2012-07-27